UnitedHealth faces unprecedented combined pressure from Medicare Advantage rate cuts, pharmacy benefit manager (PBM) regulatory scrutiny, and elevated medical cost trend that compressed margins meaningfully in 2025. Optum Health and Rx growth slowing as care utilization remains elevated. Change Healthcare cyberattack remediation costs lingering. Political risk on insurance industry profitability remains high. Long-term Optum thesis intact but near-term earnings power impaired.
Signals scoped to US · Company-specific tagging coming soon.